预期阿德罗尔会影响主观情绪和药物效应,而不考虑同时摄入咖啡因:一项随机对照试验
Alison Looby1, Annalisa V Piccorelli2, Lauren Zimmerman3
1Department of Psychology, University of Wyoming, 1000 E. University Ave, Department 3415, Laramie, WY, 82071, USA. alooby@uwyo.edu.
Psychopharmacology
|September 22, 2023
概括
期待Adderall的大学生报告了增强的主观效应,但认知表现没有改善. 这表明期望,而不是药物本身,影响非医疗处方兴奋剂使用的感知好处.
科学领域:
- 神经科学是一个神经科学.
- 心理药理学 心理药理学
- 认知心理学 认知心理学
背景情况:
- 在大学生中,非医疗处方兴奋剂 (NPS) 的使用很普遍,通常用于认知增强.
- 预期和安慰剂效应可能会导致NPS持续,尽管存在潜在的负面后果.
研究的目的:
- 调查安慰剂是否会影响主观情绪,药物效应和认知表现.
- 为了确定摄入咖啡因是否会放大Adderall相关的安慰剂效应.
主要方法:
- 一项并行随机对照试验,涉及121名具有NPS高风险的本科生.
- 参与者进行了两次实验室访问:基线对照和第二次访问与指定的条件 (对照,阿德罗安慰剂或阿德罗安慰剂与咖啡因).
- 测量包括主观情绪/药物影响和认知评估.
主要成果:
- 对于像安非他命效应,能量,效率和高兴感等主观效应,观察到显著的条件 × 访问相互作用.
- 与对照组相比,预计服用Adderall的参与者报告了更大的积极主观效应.
- 同时摄入咖啡因并没有逐渐增强这些安慰剂效应;没有发现显著的认知改善.
结论:
- 对处方兴奋剂效果的期望显著影响了高风险大学生的主观体验.
- 研究结果表明,预期挑战干预措施有潜力减轻非医疗处方兴奋剂的使用.
更多相关视频
相关概念视频
The Placebo Effect
6.2K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.2K
Stimulants
237
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
237
Adrenergic Agonists: Indirect-Acting Agents
1.7K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.7K
Attention-Deficit/Hyperactivity Disorder
85
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
85
Adrenergic Agonists: Mixed-Action Agents
771
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
771
Drugs Affecting Neurotransmitter Release or Uptake
1.1K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.1K


